After the intravenous administration of Il'1labeled L-diiodotyrosine (DIT), an increasing fraction of the labeled iodine of the serum becomes inorganic iodide as the DIT undergoes deiodination. Most of the labeled iodine which appears in the urine is inorganic iodide (1) . If one makes an estimate of the renal clearance of inorganic iodide, based on the concentrations of labeled inorganic iodide in serum and urine after the administration of DIT, then values considerably in excess of those reported for iodide (2) (3) (4) (5) are obtained. This could occur if DIT undergoes further deiodination after it enters the kidney.
The studies reported here are concerned with simultaneous measurements of the renal clearance of iodide and DIT, using a double-labeling technique with I133-labeled iodide and I131-labeled DIT. It is shown that the apparent renal clearance of I'31-labeled DIT is considerably less than the true clearance and, thus, that intrarenal deiodination of DIT does indeed occur.
MATERIALS AND METHODS
DIT labeled with 13l was prepared by iodination of L-tyrosine by the method of Roche, Lissitzky, Michel and Michel (6) . I133 in the form of iodide was obtained from Brookhaven National Laboratories. The major component of the gamma radiation of 113' has an energy of 0.53 MEV. This is sufficiently different from the major I13l gamma energy of 0.36 MEV to permit differentiation of the two isotopes in a well-type scintillation counter with pulse-height analyzer.
Five subjects were selected for study. All were healthy males with no clinical evidence of renal disease or prostatism. The ages ranged from 29 to 63 years. In three of the subjects there was no thyroidal uptake of iodide because of previous thyroidectomy or medications, and in the other two (Subjects 2 and 5), uptake of iodine by the gland was blocked with a single 30 mg. dose of methimazole. All subjects were clinically euthyroid at the time of the study.
Priming doses of 50,uc. each of I131-labeled DIT and of IP3 as iodide were given intravenously, and a maintenance solution containing 40,uc. of DIT and 20 Mc. of iodide13' in 50 ml. saline was administered by continuous I.V. drip at the rate of 2 ml. per minute. After a 30 minute period for equilibration, urine collections were made for four consecutive 30 minute periods, with a blood sample at the midpoint of each period. The labeled iodine in aliquots of each urine and serum sample was determined in the well-type scintillation counter at discriminator settings for iF1 and 1133. Urine was then applied with carrier iodide and DIT directly to Whatman No. 3 filter paper for descending chromatography in butanol-20 per cent acetic acid. Because of the low concentration of labeled iodine in the serum samples, 2 ml. aliquots were first acidified to pH 2 with H2SO4 and thrice extracted with butanol saturated with 5 per cent Na2S20,. The butanol extracts were evaporated to dryness at 650 C. and redissolved in ethanol NH3 prior to chromatography. After chromatography the strips were sprayed with palladium chloride and diazotized sulfanilic acid solutions to identify the iodide and DIT markers. Strips were then cut in segments and counted both for 1131 and I13 in the well counter. Inulin clearances were simultaneously determined by the conventional method in three of the five patients.
In order to test the accuracy of the chromatographic method for measuring the relative quantities of DIT and iodide, normal serum was incubated with four different known ratios of DIT and iodide. Samples of each were extracted, chromatographed and measured as described. The results, shown in Table I , indicate that the method 784 provides a satisfactory indication of the ratio of concentration of the labeled substances in the serum samples. Losses in the processes of extraction, transfer and chromatography were random and did not affect the ratio after three extractions.
Computations. Because the I113 available is contaminated with I131, it is necessary to apply a correction to the measured values of the labeled iodine in urine and serum at the two settings. This can be done by measuring known standards of I131 and Imn at the two settings on the pulse-height analyzer. Simultaneous equations can then be set up and solved as follows: App. CDIT = fr un X C1':' fDIT serum where fDIT urine equals the fraction of total urinary I"1 present as DIT and fDIT serum equals the fraction of total serum 1131 present as DIT. fDIT urine is always small. Similarly, an apparent renal clearance of iodide can be computed.
The true clearance of DIT is the apparent clearance plus an amount of DIT equivalent to any iodide which may have been split from DIT during passage through the kidney. Thus, the last term of Equation 1 below is an expression to add to the clearance value that iodide in the urine which was derived by breakdown of DIT in the kidney. If there were no breakdown in the kidney, the numerator of this term would vanish. 
RESULTS AND DISCUSSION
Values for C1133, C1131 and the apparent and true clearances of DIT for each of the five subjects are summarized in Table II . In Subject No. 5, the first collection period was discarded because an equilibrium state had not been reached, and CDIT could not be computed for the final period because of laboratory contamination of the chromatograms. Considerable individual variation in the renal clearance of iodide (CI133) was noted. The highest values were found in younger subjects. In the two youngest subjects, clearance values somewhat higher than those recorded in the literature (2-5) were found. There was also considerable variation in the apparent and true clearance of DIT, the ratios varying from 0.2 to 0.55. This is presumably attributable to varying degrees of deiodination of DIT in the kidney.
In each case, the true clearance of DIT was found to be greater than the apparent clearance, as estimated from serum and urine DIT concentrations. Thus, postglomerular, presumably intrarenal, deiodination of DIT must have occurred. This could have taken place either by deiodination of filtered DIT, or by direct secretion of de- rived iodide by the cells of the kidney tubules. Deiodination in the ureters or bladder could conceivably occur but seems less likely. Deiodination did not occur in urine samples which were allowed to stand overnight at room temperature. For any clearance studies to be valid, it is necessary that the substance being studied remain intact. DIT undergoes deiodination in the process of excretion; hence, it is not possible to estimate its true clearance by a single tracer technique. The true clearance can be calculated only if an independent measurement of the iodide clearance is obtained simultaneously, as by the double tracer technique described here. SUM MARY AND CONCLUSIONS 1. Simultaneous determinations of the renal clearance of I'31-labeled diiodotyrosine and 1833labeled iodide have been performed. Differential measurement of the two isotopes was found to be technically feasible.
2. The apparent renal clearance of diiodotyrosine is lower than the true clearance because of intrarenal deiodination of diiodotyrosine.
